Alzheimer's disease (AD) is the most prevalent neurodegenerative disease in the growing population of elderly people. A hallmark of AD is the accumulation of plaques in the brain of AD patients. The plaques predominantly consist of aggregates of amyloid-beta (Abeta), a peptide of 39-42 amino acids generated in vivo by specific, proteolytic cleavage of the amyloid precursor protein. Recent findings however suggest that smaller oligomeric forms of Abeta, formed in parallel to the amyloid plaques, excert the predominant tissue damaging effect.Specific identification of the oligomeric forms is as a consequence of great interest. Based on a recently published technique a highly oligomer-specific antibody (mAB-M), targeting Abeta oligomers while omitting reactivity towards the monomeric and fibrillar counterpart, has been developed.
應(yīng)用類型
Dot blot (Dot), ELISA (ELISA), Immunolocalization (IL)
免疫原
synthetic peptide chosen from human Abeta protein (3-10) pregion, oligomer specific
來(lái)源宿主
小鼠
反應(yīng)性
人
保存建議
For short time storage please add sodium azide and srote at +4